TABLE 1.
Summary of preclinical studies evaluating the effects of SCU in different diseases.
Model | Main Target | Disease | Tissue | Reference | ||
---|---|---|---|---|---|---|
Male SD rats | MCAO-induced brain damage | In vivo | PARP↓, NAD↓ | I/R injury | Brain | Zhang et al. (2009) |
Female SD rats | — | In vivo | GAP43↑, PTN↓, JAK2↓, STAT↓ | I/R injury | Brain | Niu et al. (2021) |
Primary cortical neurons | In vitro | |||||
SD rats | MCAO-induced brain damage | In vivo | p65↓, p38↓, ROS↓, MDA↓, SOD↑, CAT↑ | I/R injury | Brain | Zhang et al. (2022f) |
GSH-Px↑, GSH↑, IL-1↓, IL-6↓, TNF-α↓ | ||||||
Rats | MCAO-induced brain damage | In vivo | SOD↑, CAT↑, GSH↑, ROS↓ | I/R injury | Brain | Guo et al. (2011a) |
Rat cortical neurons | In vitro | |||||
C57BL/6N mice | MCAO-induced brain damage | In vivo | NOX1↓, NOX2↓, NOX4↓ | I/R injury | Brain | Deng et al. (2022) |
AR−/− mice | ||||||
Male SD rats | MCAO-induced brain damage | In vivo | eNOS↑, VEGF↓, bFGF↓, iNOS↓ | I/R injury | Brain | Hu et al. (2005) |
Male SD rats | MCAO-induced brain damage | In vivo and in vitro | NOX2↓, 8-OHdG↓, 4-HNE↓, 3-NT↓ | Sun et al. (2018c) | ||
Primary astrocytes | caspase-3↓, NeuN↓, connexin 43↑ | |||||
Wistar rat, Neuronal cells | Neuron damage induced by hydrogen peroxide | In vitro | cNOS↓, NO↑ | Neuron damage | Brain | Liu et al. (2005) |
SD rats | MCAO-induced brain damage | In vivo | PKG↑ | Cerebral ischemia | Brain | Chen et al. (2021b) |
Rat brain microvascular | — | In vitro | NO↑, CD63↑, claudin 5↑, occludin↑, ZO1↑, LDH↓, ROS↓ | Cerebral ischemia | Brain | Zhong et al. (2019) |
Endothelial cells | ||||||
Rats | MCAO-induced brain damage | In vivo | XOD↓, ALT↓, AST↓, MDA↓ | I/R injury | Brain/Liver | Yang et al. (2003) |
BV-2 cells, TNC1 astrocytes | MCAO-induced brain damage | In vitro | GFAP↑, Notch-1↑, NICD↑, HES-1↑, TNF-α↑, IL-1β↑, iNOS↑ | Cerebral ischemia | Brain | Fang et al. (2015) |
Male SD rats, BV-2 cells | MCAO-induced brain damage | In vivo and in vitro | NF-κB↓, Notch-1↓, NICD↓, RBP-JK↓, Hes-1↓ MCP-1↓ | Cerebral ischemia | Brain | Yuan et al. (2015) |
Male SD rats | MCAO-induced brain damage | In vivo and in vitro | p-p38↓, p-JNK↓, p-ERK1/2↑, iNOS↓, TNF-α↓, IL-1β↓ | Cerebral ischemia | Brain | Chen et al. (2020) |
BV-2 cells | LPS induced BV-2 cells | p-JNK↓, p-p38 MAPKs↓ | ||||
SD rats | MCAO-induced brain damage | In vivo | ACE↓, AT1R↓, Ang II↓, TNF-α↓, IL-6↓, IL-1β ↓ | Cerebral ischemia | Brain | Wang et al. (2016a) |
Male Wistar rats | BCCAO-induced brain damage | In vivo | Glu↓, Asp↓, Gly↓, GABA↓, Tau↓, Ca 2+-ATPase↑ | Cerebral ischemia | Brain | Tang et al. (2014) |
Na +, K +-ATPase↑ | ||||||
SD rats | — | In vitro | p-VASP↑ | Hypoxia | Coronary artery | Chen et al. (2015) |
SD rats, | Rats with cerebral I/R treatment | In vivo | P-VASP↑, PKG↑ | Hypoxia | Brai | Du et al. (2015) |
HBMECs | In vitro | |||||
Male SD rats, BV-2 cell | MCAO-induced brain damage | In vivo and in vitro | cyclin B1↑, cyclin B1↑, cyclin D1↑, NT-3↑ | Cerebral ischemia | Brain | Fang et al. (2016) |
IGF-1↑, AP-2↑, PSD-95↑ | ||||||
Male SD rats | — | In vivo | eNOS↑, p-Erk5↑, KLF2↑ | Subarachnoid hemorrhage | Brain | Li et al. (2016) |
Male SD rats | LPS-induced behavioral deficits | In vivo | ROS↓NLRP3, caspase-1, IL-1β↓ | Depression | Brain | Bian et al. (2020) |
Wistar rats | — | In vivo | IL-1β↓, IL-6↓, TNF-α↓, SOD↑, MAO↓ | Depression | Brain | Guo et al. (2013) |
Male C57BL/6 mice | Depression-like behaviors | In vivo | TNFα↓, IL-1β↓, IL-6↓, iNOS↓, IL-4↑, BDNF↑ | Depression | Brain | Lu et al. (2021) |
Primary astrocytes | induced by LPS | In vitro | ||||
Male C57BL/6 mice | — | In vivo | GABAA Rα1↓, GABAAγ2↓, mEPSC↓ | Anxiety disorders | Brain | Guo et al. (2021) |
MCF-7 cells | — | In vitro | Aggregation of beta-amyloid↓ | Alzheimer's disease | Brain | Zhu et al. (2009) |
Male APPswe/PS1dE9 mice | — | In vivo and in vitro | Aβ aggregation↑, soluble Aβ oligomers↓, Aβ42↓, Aβ40↓ | Alzheimer's disease | Brain | Zhang et al. (2020) |
C57BL/6 mice | ||||||
BV-2 cells | — | In vitro | NO↓, TNFα↓, IL-1β↓, ROS↓, iNOS↓, TNFα↓, IL-1β↓ | Alzheimer's disease | Brain | Lu et al. (2021) |
SH-SY5Y cells | NF-κB↓, JNK↓, p38↓, IFN-γ↓, STAT1α↓ | |||||
HT22 cell | — | In vivo and in vitro | Lactate dehydrogenase↓, lactate dehydrogenase↓, ROS↓, Aβ1‑42↑ | Alzheimer's disease | Brain | Chiba et al. (2012) |
Balb/c male mice | p-Tau↓, ROS↓, Bcl-2↑, Bcl-xL↑, Bax↓, cleaved caspase-3↓ | |||||
APP/PS1 transgenic mice | — | In vivo and in vitro | Aβ plaque↓, TNF-α↓, IL-6↓ | Alzheimer's disease | Brain | Zeng et al. (2018) |
WT mice, H-SY5Y cell line | ||||||
Male SD rats | Permanent bilateral | In vivo | Aβ (1-40) ↓, Aβ (1–42) ↓, Iba1↓ | Vascular dementia | Brain | Shin et al. (2018) |
Common carotid artery occlusion | Alzheimer's disease | |||||
Male Wistar rats | In vivo | nAChR↑, nAChR α4↑, α7↑ | Cognitive disorder | Brain | Guo et al. (2011b) | |
APP/PS1 transgenic mice | — | In vivo | SCFAs, IL-1β↓ | Alzheimer's disease | Brain | Zhang et al., (2022c) |
BALB/cmale mice | — | In vivo | MDA↓, SOD↑, IL-1β↓, IL-6↓, HO-1↓, NQO1↑, Nrf2↓ | Alcohol induced brain injury | Brain | Zhang et al. (2022d) |
BV-2 cells | — | In vitro | NF-κB-p65↓, TNF-α↓, IL-1β↓, IL-6↓, NO↓, TNF-α↓, IL-1β↓ | neuroinflammation | Brain | You et al. (2018) |
IL-6↓, iNOS↓, IκB↓, IKKβ↓, p38↓, JNK↓, AKT↓ | ||||||
Male albino Wistar rats | — | In vivo | MDA↓, SOD↑, GSH↑, AChE↓, NF-κB↓, TNFα↓, IL-6↓ | Cognitive disorder | Brain | Baluchnejadmojarad et al. (2018) |
Nrf2↑, beclin-1↓, LC3 II↓, mTOR↓, P62↓ | ||||||
Male C57BL/6 mice | — | In vivo and in vitro | nestin↑, Tuj-1↑, ERK1/2↑ | Cognitive disorder | Brain | Wang et al. (2017) |
Neural stem cells | ||||||
Male Wistar albino rats | Metanil yellow induced | In vivo | GFAP↓, cleaved caspase-3↓, MDA↓, SOD↑, GSH↑ | Gliosis | Brain | Tawfeek et al. (2021) |
Male SD rats | — | In vivo | TLR4↓, NF- κ B p65↓, TNF- α↓, IL-1 β↓, IL-18↓ | Hypertension | Brain | Chen et al. (2013) |
Bax↓, cleaved-caspase-3 p17↓, Mcl1↑ | ||||||
Male SD rats | — | In vivo | CTn-T↓, CTn-I↓, AST↓, LDH↓, SOD↑, CAT↑GSH↑ | Myocardial infarction | Heart | Huang et al. (2018) |
Caspase3↓, Caspase9↓, cytochrome C↓, NGAL↓, NFκB↓, IL-1β↓ | ||||||
P53↓, IL-6↓, Bcl2↑, MDA↓, iNOS↓, Bax↓ | ||||||
Male Wistar rats | — | In vivo | FN1↓, TGFβ1↓, CFs↓, p38-MAPK↓, ERK1/2↓ | Cardiac fibrosis | Heart | Pan et al. (2011) |
Male SD rats | — | In vivo | LVWI↓, RVWI↓, type I and type III collagen↓, MVD↑, CD31↑ | Cardiac fibrosis | Heart | Zhou et al. (2014) |
α-sma ↓, Jagged1↑, Notch 1↑, Hes1↑ | ||||||
C57BL/6 mice | — | In vitro and in vivo | CaMKII↓, β-MHC↑, ANP↑ | Cardiac hypertrophy | Heart | Pan et al. (2010) |
Cardiac myocytes | ||||||
SD rats, H9c2 cells | — | In vitro and in vivo | NLRP3↓, mTORC1↓, p-Akt↑, Casp-1↓, IL-1β↓ | Myocardial I/R injury | Heart | Xu et al. (2020) |
Rats, endothelial cell | — | In vitro and in vivo | P-JAK↓, P-STAT3↓ | Myocardial I/R injury | Heart | Lin et al. (2014) |
HCMECs | — | In vitro | JAK2↓, p-JAK2↓, STAT3↓, p-STAT3↓ | Myocardial ischemia | Heart | Chen et al. (2019) |
H9c2 cells | — | In vitro | JAK/STAT3↑, Bcl2↑, VEGF↑, MMP2↑, MMP9↑, TNFα↓ | Myocardial I/R injury | Heart | Wang et al. (2016b) |
IL-8↓, CK ↓, NO↑, ROS↓, SOD ↑, MDA ↓, STAT3↑, Bcl2↑ | ||||||
VEGF↑, MMP2↑, MMP9↑, IL-1β↓, IL-6↓ | ||||||
HCMECs | — | In vitro | EIF6↓, HSPD1↑, CCT6A↑ | Anoxia | Heart | Shi et al. (2015) |
HCMECs, SD rats | MIR model | In vitro and in vivo | PKG-I↑, PKG-Iα↑ | Myocardial I/R injury | Heart | Li et al. (2015) |
Male SD rats | LPS induced lung injury | In vivo | ROS↓, SOD↓, IL-1β↑, IL−18↑, IL−6↑, IL−4↑, IL−10↑, MDA↓ | Lung injury | Lung | Fan et al. (2022) |
Mice | Injected with a dose of LPS | In vivo | TNF-α↓, iNOS↓, c-Fos↓, iNOS↓, NF-kappaB↓, IkBa↓, GSH↑ | Lung injury | Lung | Tan et al.(2010) |
Male albino rats | Rat Model of Bilateral | In vivo | iNOS↑, Bax↑, Bcl2↓, COX2↓ | Posterior limb I/R injury | Lung | Ibrahim et al. (2019) |
Hind Limb I/R | ||||||
HBE-16 cell | In vitro | MUC5AC↓, p-PKC↓, ERK1/2↓ | Airway mucus secretion | Lung | Jiang et al. (2011b) | |
HBE-16 cell, Male SD rats | In vivo and in vitro | MUC5AC↓, PKC↓, ERK1/2↓ | Airway mucus secretion | Lung | Jiang et al. (2011a) | |
Male BALB/c mice | BLM-induced | In vivo and in vitro | p-p65/p65 ratio↓, IκBα↓NLRP3↓, caspase-1↓, caspase-11↓, IL-1β↓ | Pulmonary fibrosis | Lung | Peng et al. (2020) |
A549 cell, RLE-6TN cell | IL-18↓, fibronectin↓, vimentin↓, N-cadherin↓, MMP-2↓, MMP-9↓ | |||||
HK-2 cells, Wistar rats | — | In vitro and in vivo | HO-1↑, SCr↓, BUN↓, KIM-1↓, ROS↓ | I/R injury | kidney | Dai et al. (2022) |
HK-2 cells | — | In vitro | NGAL↓, Kim-1↓, cystatin C↓, IL-18↓, NLRP3↓, CCN1↑ | Hyperuricemia | kidney | Li et al. (2020a) |
Male C57BL/6 mice | In vivo | |||||
Male C57BL/6 mice | — | In vivo | BUN↑, CRE↑, TNF-α↓, IL-6↓, Cleaved caspase-3↓ | Chemotherapy toxicity | kidney | Sun et al. (2019) |
Cleaved PARP↓, p53↓, Bax/Bcl-2↓, LC3-II/LC3-I↑, Atg7↑ | ||||||
p62↓JNK↓, ERK↓, p38↓, stat3↓ | ||||||
HepG2 cells | Acid-treated HepG2 cells | In vivo | XBP1↓, SREBP-1c↓, IRE1α↓ | NAFLD | Liver | Zhang et al. (2022e) |
C57/BL6 mice | HFD-induced | In vitro | ||||
HepG2 cells | — | In vitro | CD36↓, Fasn↓, ACC↓, AKT↑, mTOR↓, n-SREBP-1c↓ | Hepatocyte lipid metabolism | Liver | Han and Wang (2018) |
Male C57BL/6 mice | In vivo | |||||
Mice | HFD-induced | In vivo and in vitro | SREBP-1c↓, mTOR↓ | Hepatocyte lipid metabolism | Liver | Luan et al. (2020) |
HepG2 cells | PA-treated HepG2 cells | |||||
Male C57BL/6 mice | HFD induced mice | In vivo and in vitro | PPARγ↑, PGC-1α↑, Nrf2↑, HO-1↑, GST↑, NQO1↑ | NAFLD | Liver | Zhang et al. (2018) |
HepG2 cells | Oleic acid induced cells | NF-κB↓, Keap1↓ | ||||
SD rats | HFD-induced | In vivo | Nrf2, HO-1, and PI3K, and AKT ↑HO-1, NQO1, and Nrf2↑ | NAFLD | Liver | Fan et al. (2017) |
subjected to chronic stress | ||||||
BALB/c mice | CCl4-induced liver injury | In vivo | AST↓, ALT↓, TBIL↓, IL-1β↓, TNF-α↓, CYP2E1↓, IκBα/NF-κB↓ | Hepatotoxicity | Liver | Miao et al. (2021) |
S180 tumor-bearing mic | DB-induced liver injury | In vivo | MPO↑, IκB↓, NF-κB p65↓, TNF-α↓, IL-6↓, IFN-γ↓, MDA↓, GPx↑ | Hepatotoxicity | Liver | Niu et al. (2015) |
Male ICR mice | Induced by concanavalin A | In vivo | ALT↓, AST↓, TNF-α↓, iNOS↓, c-Fos↓, c-Jun↓, iNOS↓, IkappaB↑ | Hepatitis autoimmune | Liver | Tan et al. (2007) |
Male Wistar rats | Se-treated rats | In vivo | MDA↑, GSH-Px↑, TR↑ | Hepatotoxicity | Liver | Eltayeb et al. (2004) |
HL-7702 | Under hypoxic condition | In vitro | ROS↓, MDA↓, SOD↑, bcl-2↑, Keap1↓ Nrf2↑, HO-1↑, NQO1↑, Nrf2↓ | I/R injury | Liver | Wu and Jia (2019) |
Chondrocytes | — | In vitro | MMP1↓, MMP13↓, ADAMTS-5↓, Wnt3a↓, Frizzled7↓ | Osteoarthritis | Bones and joints | Liu et al. (2020) |
C57BL/6 male mice | In vivo | Collagen II↑, Aggrecan↑ | ||||
C57BL/6 mice | — | In vivo and in vitro | MMP-13↓, ADAMTS-5↓, COX-2↓, iNOS↓, IL-6↓, | Osteoarthritis | Bones and joints | Luo et al. (2020) |
Chondrocytes | TNF-α↓, PGE2↓, IL-1β↓, NF-κB↑, Nrf2↑ | |||||
BL6/C57 male mice | — | In vivo and in vitro | TNF-α↓, IL-1β↓, iNOS↓, MMP13↓, ADAMTS-5↓ | Osteoarthritis | Bones and joints | Wang et al. (2019) |
Chondrocyte cells | COX-2↓, IL-6↓, NO↓ | |||||
SW1353 cells | — | In vitro | IL-6↓, AKT↓, mTOR↓, p-mTOR↓, CH25H↓ | Osteoarthritis | Bones and joints | Ju et al. (2021) |
CYP7B1↓, ABCA1↑, APOA-1↑ | ||||||
Human Enucleus | — | In vivo and in vitro | ROS↓, NF-κB↓, MAPK↓, TNF-α↓, NLRP3↓ | Intervertebral | Bones and joints | Wang et al. (2022b) |
Pulposus Cells | disc degeneration | |||||
Male SD rats | ||||||
SD rats | — | In vivo and in vitro | ATG5↑, Rab8a↑, PI3K↑, PTEN↑, Akt↑ | Intervertebral | Bones and joints | Hu et al. (2022) |
Nucleus pulposus cells | disc degeneration | |||||
Male DBA/1J mice | collagen‑induced arthritis | In vivo | IL‑1β↓, IL‑6↓, TNF‑α↓, Caspase‑3/-9↓Bax/Bcl‑2↓TLR4↓NF‑κB↓ | Arthritis | Bones and joints | Zhang et al., (2017) |
Raw264.7 cell line | — | In vivo and in vitro | RANKL↓, MAPK↓, NF-κB↓, JNK1/2↓, p38↓, ERK1/2↓, IκBα↓ | Arthritis | Bones and joints | Zhao et al. (2016) |
C57BL/6 male mice | ||||||
Osteoblasts female SD rats | — | In vivo and in vitro | ALP secretion↑, intracellular calcium ion influx↑ | Osteoporosis | Bones and joints | Wang et al. (2018) |
calcium deposition↑, CXCR4↑, p65↑ | ||||||
3T3-L1 cells | In vitro | PPARγ↓ C/EBPα↓ | Obesity | Metabolic disease | Lu et al. (2013) | |
db/db mice db/m+ mice | — | In vivo | Nrf2↑, HO-1↑, IL-1β↓, IL-2↓, IL- 4↑ | Diabetic Nephropathy | Diabetic complication | Liu et al. (2019b) |
C57BL/6 male mice | — | In vitro and in vivo | laudin-1↑, claudin-19↑, NFκB↓, TNF-α↓, p-ERK 1/2↓, Nrf2↑ | Diabetic retinopathy | Diabetic complication | Mei et al. (2019) |
WT mice and HRECs | ||||||
Human retinal endothelial cells | — | In vitro | VEGF↓, p-ERK↓, p-FAK↓, p-Src↓ | Diabetic retinopathy | Diabetic | Long et al. (2019) |
Rats | In vivo | complication | ||||
Male Wistar rats | — | In vivo | MDA↓, ROS↓, Bcl-2↑, BAX↓, VEGF↑ | Testicular Damages | Diabetic | Long et al. (2015) |
complication | ||||||
Male SD rats | — | In vivo | blood glucose↓, TC↓, TG↓ LDL↓, HDL↑, LDH1↓, CK↓, | Diabetic cardiomyopathy | Diabetic | Su et al. (2022) |
Beclin-1↑, LC3-II↑ | complication | |||||
Male Swiss mice | HFD-induced | In vivo | CK-MB↓, Troponin↓, BNP↓, SOD↑, CAT↑, GPx↑, GST↑, Nrf2↓ | Diabetic cardiomyopathy | Diabetic | Huo et al. (2021) |
Nqo-1↓, Ho-1↓, Tlr4↓, Myd88↓, Nf-κb↓, IL-6↓, TNf-α↓, IKKβ↑ | complication | |||||
Cyt-c↓, Parp 1↓, bcl-2↑, caspase-3↓, caspase-9↓, Bax↓ | ||||||
HUVECs | — | In vitro | Bcl-2↓, Bax↓ Cyt c↓, ROS↑, SOD↑, SOD2↑, LC3 II↑, Beclin 1↑ | Diabetic | Diabetic | Xi et al. (2021) |
Atg 5↑, PINK1↑, Parkin↑, Mitofusin2↑ | cardiomyopathy | complicatio | ||||
Male C57/B6 mice | — | In vivo | NLRP3↓, NF-κB↓, p-AKT↓, Nrf2↓, HO-1↓, EF↓, LVVd↓ | Diabetic | Diabetic | Xu et al. (2021) |
CK↓, Col I↓, TGF-β1↓, SOD↑, CAT↑, GSH-Px↑, MDA↓ | cardiomyopathy | complication | ||||
ROS↓, IL-1β↓, IFN-γ↓, IL-6↓, MCP-1↓, TNF-α↓, IL-18↓ | ||||||
LDH↓, cTnI↓ | ||||||
LO2 | Induced by Hcy | In vivo and in vitro | Hcy↓, TG↓, CHO↓, LDL↓, ALT↓, AST↓, insulin↓, CBS↓, CSE↓ | Diabetic | Diabetic | Wang et al. (2020) |
Male SD rats | High-fat induced | MTHFR↓, folic acid↑, VitB6↑, VitB12↑ | Liver Injury | complication | ||
PC-9, H1975, Hela cells | — | In vitro | p-ERK1/2↑ ERK1/2↓, p-AKT↓, AKT↓, LC3-II↓ | Lung cancer | Cancer | Sun et al. (2018a) |
HepG2, Beas-2B cells | p-ERK1/2↑, p-AKT↓ | |||||
A549 cells | — | In vitro | G0/G1↓, AKT↓, mTOR↓, BCL-XL↓, STAT3↓, p-STAT3↓, 4EBP1↑ | Lung cancer | Cancer | Cao et al. (2019) |
A549 cells | — | In vitro | ROS↑, caspase-3↑, TGF-β1↓ | Lung cancer | Cancer | Zhang et al. (2021) |
HepG2 and MHCC97-H cells | — | In vitro | EMT↓, p-JAK2↓, p-STAT3↓ E‐cadherin↑, snail↓, vimentin↓ | Liver cancer | Cancer | Liu et al. (2019a) |
HepG2 and SK-Hep1 cells | — | In vitro | STAT3↓, Girdin↓, AKT↓ | Liver cancer | Cancer | Ke et al. (2017) |
Male BALB/c nude mice | In vivo | |||||
C57BL/6 male mice | CAC caused by AOM/DSS | In vivo and in vitro | NF-κB↓, SHH↓, Ptch1↓, Smo↓, Gli1↓ | Colorectal cancer | Cancer | Zeng et al. (2022) |
SW480 cells | ||||||
SW620, HCT116, LOVO | — | In vitro and in vivo | ephrinb2↓, ephB6↓, ephA1↓ | Colorectal cancer | Cancer | Zhu et al. (2017) |
HT29 cells and Balb/c nude mice | ||||||
HT-29 CSC cells | — | In vitro and in vivo | Lgr5↓, c-Myc↓, CK20↓, Nanog↓, Gli1↓, CD133↓, Lgr5↓ | Colorectal cancer | Cancer | Lei et al. (2020) |
Nude mice | Gli1↓, Ptch1↓, c-Myc↓, Ki-67↓, CK20↓ | |||||
HCT116 p53+/+ (wild-type) | — | In vitro | caspase-6↑ | Colorectal cancer | Cancer | Chan et al. (2009) |
p53-/- (knockout) cells | ||||||
Male C57BL/6 mice | Induced by azoxymethane and | In vivo | Wnt/β-catenin↓, TNF-α↓, IL-6↓, Bax↑ | Colorectal cancer | Cancer | Zeng et al. (2021) |
HT-29 cells | dextran sulfate sodium | In vitro | Bcl-2↓, GSK-3β↓, cyclin D1↓ | |||
Mice | — | In vivo | p38 MAPK↓, TNFR2+Tregs↓, CD8+T↑ | Colorectal cancer | Cancer | Chen et al. (2022) |
WEHI-13VAR and CT26 cell | In vitro | |||||
HCT‑116 cells | — | In vitro | Bcl‑2↓, Bax↑, caspase‑3↑, p-p53↑ | Colorectal cancer | Cancer | Yang et al. (2017) |
AGS | — | In vitro and in vivo | LDH↓, G0-G1↑S↓, G2-M↓, SOD↑, GSH↑, CAT↑, MDA↓, 8-OHdG↓ | Gastric cancer | Cancer | Sun and Meng (2022) |
MGC-803 and AGS | — | In vitro | PI3K↓, PTEN↑ | Gastric cancer | Cancer | Li et al. (2021) |
SAS cells | — | In vitro and in vivo | MMP-2 and -9↓, integrin αvβ6↓, c-JUN↓ | Oral squamous cell carcinoma | Cancer | Li et al. (2013) |
Athymic Balb/ca nude mice | ||||||
SAS and HSC-4 cells | — | In vitro | E-cadherin↑, αvβ6 integrin↓ | Oral squamous cell carcinoma | Cancer | Li et al. (2010) |
C57BL/6J mice | — | In vivo | retinal thinning and reduced visual behavioral deficits | Glaucoma | Eye | Pang and Clark (2020) |
Female C57BL/6 mice | LPS-primed macrophages | In vivo and in vitro | NLRP3↓, IL-1β↓, caspase-1 ↓ | Sepsis | Multiple Organ | Liu et al. (2017) |